📰 Our Technology Access Programmes News
Our Technology Access Programmes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Our Technology Access Programmes. Real-time updates on events, politics, business and more.
October 18, 2023
In this article, discover how Sphere Fluidics helped Biosyntia with its synthetic and metabolic workflows, allowing for the efficient development of more sustainable products.
May 26, 2023
In this article, Sphere Fluidics demonstrates how they perform rapid and efficient cell screening of IgG-secreting mammalian cells in order to isolate high-producing clones.
May 26, 2023
In this article, Sphere Fluidics demonstrates how its Cyto Mine instrument can conduct a high-throughput method for identifying rare antigen secreting cells from B cell repertoires and hybridoma fusions.
May 26, 2023
In this article, Sphere Fluidics showcases a method by which to screen and isolate high value rare cells that possess assured clonality.
March 16, 2023
In this article, Sphere Fluidics provides a brief introduction to the process of cell engineering in picodroplets.
March 16, 2023
In this article, Sphere Fluidics showcases a high-throughput method of effectively identifying and isolating rare cells that secrete antibodies.
March 16, 2023
In this article, Sphere Fluidics discusses the best practices for enhancing cell line development and how to implement them in research and development.
March 3, 2023
Uniform picoliter volume droplets, also known as picodroplets, can be utilized as 'test tubes' for high-throughput bioassays. The utilization of picodroplets allows for novel bioassays to be used, thus aiding biotherapeutic development, cell therapy, genome editing, and more.